Finance

Lists
ZYDUSLIFE:NSE
Zydus Lifesciences Ltd
₹1 123,00
-1,51%
(-17,20) 1D
16 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ZYDUSLIFE...
Open
₹1 140,10
High
₹1 146,50
Low
₹1 123,00
Mkt. cap
1,12 bn
Avg. vol.
1,42 m
Volume
1,60 m
Dividend
0,09%
Quarterly dividend
₹0,25
Ex-dividend date
24 Jul. 2026
P/E ratio
25,03
52-wk high
₹1 232,10
52-wk low
₹835,50
EPS
₹44,87
No. of employees
30 k
Open
₹1 140,10
High
₹1 146,50
Low
₹1 123,00
Mkt. cap
1,12 bn
Avg. vol.
1,42 m
Volume
1,60 m
Dividend
0,09%
Quarterly dividend
₹0,25
Ex-dividend date
24 Jul. 2026
P/E ratio
25,03
52-wk high
₹1 232,10
52-wk low
₹835,50
EPS
₹44,87
No. of employees
30 k
News stories
From web sources and news partners
Profile
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad. Primarily engaged in the manufacturing of generic drugs, the company ranked 100th in the Fortune India 500 list in 2020. Wikipedia
About Zydus Lifesciences Ltd
CEO-
Employees30 k
Founded1952
Headquarters-
SectorPharmaceutical industry
Last report
11 Aug. 2026
Fiscal period
Q1 2027
₹9,48 / ₹11,15
-14,98%miss
Revenue / Est. (INR)
80,17 mjd / 76,87 mjd
+4,30%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
61,23 mjd
68,64 mjd
75,87 mjd
80,17 mjd
Cost of goods sold
16,90 mjd
18,36 mjd
22,07 mjd
22,40 mjd
Cost of revenue
16,90 mjd
18,36 mjd
22,07 mjd
22,40 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,34 mjd
11,40 mjd
32,92 mjd
13,68 mjd
Operating expense
31,33 mjd
37,36 mjd
39,40 mjd
44,59 mjd
Total operating expenses
48,23 mjd
55,72 mjd
61,48 mjd
66,99 mjd
Operating income
13,00 mjd
12,92 mjd
14,39 mjd
13,18 mjd
Other non operating income
1,09 mjd
1,11 mjd
-3,70 mjd
1,06 mjd
EBT including unusual items
16,93 mjd
14,11 mjd
16,59 mjd
13,44 mjd
EBT excluding unusual items
17,27 mjd
14,96 mjd
20,88 mjd
13,63 mjd
Income tax expense
4,54 mjd
3,88 mjd
3,18 mjd
3,54 mjd
Effective tax rate
26,82%
27,52%
19,19%
26,35%
Other operating expenses
17,97 mjd
22,36 mjd
1,28 mjd
25,36 mjd
Net income
12,59 mjd
10,42 mjd
12,72 mjd
9,40 mjd
Net profit margin
20,55%
15,18%
16,77%
11,72%
Earnings per share
12,76
10,96
15,84
9,48
Interest and investment income
-
-
4,24 mjd
-
Interest expense
-1,01 mjd
-1,30 mjd
-491,00 m
-1,56 mjd
Net interest expenses
-1,01 mjd
-1,30 mjd
3,75 mjd
-1,56 mjd
Depreciation and amortization charges
3,02 mjd
3,60 mjd
5,08 mjd
5,55 mjd
EBITDA
15,70 mjd
15,10 mjd
17,74 mjd
16,53 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme